Pharmacy alerts

  • Pancreatic enzyme replacement therapy (PERT) NatPSA/2024/013/DHSC shortage

    Patient Safety Alert: The MHRA has published an additional Patient Safety Alert on the shortage of pancreatic enzyme replacement therapy (PERT) NatPSA/2024/013/DHSC.

    Read more

  • Indefinite ban on the supply of puberty blockers

    To children and young people under 18 years of age.

    Read more

  • Legislative changes to widen access to naloxone

    Following a consultation by the Department of Health and Social Care (DHSC), the Human Medicines Regulations (2012) (HMR) have been changed to widen access to naloxone. These changes come into force today (2 December 2024).

    Read more

  • Lexon UK Ltd, Moclobemide 150mg tablets defect

    Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for moclobemide 150mg tablets.

    Read more

  • GLP-1 receptor agonists, reminder of potential side effects

    Drug safety update: The MHRA has published a reminder of the potential side effects and to be aware of the potential for misuse.

    Read more

  • Molybdenum-99/Technetium99m generators shortage

    National Patient Safety Alert: The DHSC has issued a National Patient Safety Alert on the shortage of Molybdenum-99/Technetium99m generators.

    Read more